| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007155489 |
| P356 | DOI | 10.1136/ARD.2010.146068 |
| P932 | PMC publication ID | 3184239 |
| P698 | PubMed publication ID | 21784729 |
| P5875 | ResearchGate publication ID | 51517043 |
| P50 | author | Paul Emery | Q19859634 |
| Philip G Conaghan | Q37829390 | ||
| Mahboob Rahman | Q114079310 | ||
| P2093 | author name string | Edward C Keystone | |
| Mikkel Østergaard | |||
| Mark C Genovese | |||
| Elizabeth C Hsia | |||
| Weichun Xu | |||
| P2860 | cites work | Applying concepts of generalizability theory on clinical trial data to investigate sources of variation and their impact on reliability | Q30983779 |
| Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study | Q34601527 | ||
| Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study | Q34619338 | ||
| The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy | Q34626882 | ||
| New developments in imaging in rheumatoid arthritis | Q35111861 | ||
| OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system | Q35144341 | ||
| OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging Module. | Q35144345 | ||
| Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group | Q35549474 | ||
| MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy | Q37018344 | ||
| The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study | Q37270877 | ||
| Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting | Q39737972 | ||
| Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients | Q39958466 | ||
| Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis | Q40576539 | ||
| Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. | Q43073143 | ||
| Rheumatoid arthritis: follow-up and response to treatment. | Q50632237 | ||
| No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. | Q53263938 | ||
| Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients | Q56419586 | ||
| Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis | Q56420714 | ||
| MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) | Q56974121 | ||
| New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier | Q73774973 | ||
| A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope-positive patients and predictive of erosions at 1 year | Q73807084 | ||
| Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group st | Q79765442 | ||
| A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis | Q79936459 | ||
| The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis ma | Q80955821 | ||
| Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression | Q81549985 | ||
| Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease | Q81918700 | ||
| Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial | Q82690898 | ||
| P4510 | describes a project that uses | magnetic resonance imaging | Q161238 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| patient | Q181600 | ||
| rheumatoid arthritis | Q187255 | ||
| methotrexate | Q422232 | ||
| P304 | page(s) | 1968-1974 | |
| P577 | publication date | 2011-07-21 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial | |
| P478 | volume | 70 |
| Q51759356 | A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results fr |
| Q47875926 | Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study |
| Q54917641 | Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study. |
| Q38922606 | Baseline MRI bone erosion predicts the subsequent radiographic progression in early rheumatoid arthritis patients who achieved sustained good clinical response. |
| Q38050210 | Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective |
| Q38650245 | Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis |
| Q35788326 | Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy |
| Q36337258 | Current imaging strategies in rheumatoid arthritis |
| Q46916232 | Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging. |
| Q46105872 | Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings |
| Q38842603 | Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review |
| Q35540004 | Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis |
| Q38771878 | Golimumab: A Review in Inflammatory Arthritis |
| Q36732733 | Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years |
| Q38194473 | Heading toward a modern imaging approach in juvenile idiopathic arthritis |
| Q38590254 | Imaging in rheumatoid arthritis: options, uses and optimization |
| Q85197188 | Imaging: Use of MRI as an outcome measure in clinical trials in RA |
| Q37012723 | Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial |
| Q30698398 | Insights into rheumatoid arthritis from use of MRI. |
| Q35605451 | MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16. |
| Q50127594 | MRI assessment of erosion repair in patients with long-standing rheumatoid arthritis receiving double-filtration plasmapheresis in addition to leflunomide and methotrexate: a randomized controlled trial |
| Q47094309 | Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring. |
| Q37587412 | Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis |
| Q37715992 | The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy |
| Q27014889 | Updating the OMERACT filter: implications for imaging and soluble biomarkers |
| Q97423719 | Whole-Body Magnetic Resonance Imaging Assessment of Joint Inflammation in Rheumatoid Arthritis-Agreement With Ultrasonography and Clinical Evaluation |
Search more.